Progressive alterations in the hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model of Huntington's disease
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Huntington's disease (HD) is characterized by a triad of motor, psychiatric and cognitive symptoms. Although many of these symptoms are likely to be related to central nervous system pathology, others may be due to changes in peripheral tissues. The R6/2 mouse, a transgenic model of HD expressing exon 1 of the human HD gene, develops progressive alterations in the hypothalamic-pituitary-adrenal axis, reminiscent of a Cushing-like syndrome. We observed muscular atrophy, reduced bone mineral density, abdominal fat accumulation and insulin resistance in the mice. All these changes could be consequences of increased glucocorticoid levels. Indeed, hypertrophy of the adrenal cortex and a progressive increase in serum and urine corticosterone levels were found in R6/2 mice. In addition, the intermediate pituitary lobe was markedly enlarged and circulating adreno-corticotrophic hormone (ACTH) increased. Under normal conditions dopamine represses the ACTH expression. In the R6/2 mice, however, the expression of pituitary dopamine D2 receptors was reduced by half, possibly explaining the increase in ACTH. Urinary samples from 82 HD patients and 68 control subjects were analysed for cortisol: in accord with the observations in the R6/2 mice, urinary cortisol increased in parallel with disease progression. This progressive increase in cortisol may contribute to the clinical symptoms, such as muscular wasting, mood changes and some of the cognitive deficits that occur in HD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ultimately, excessive ACTH leads to activation and hypertrophy of the adrenal cortex in aged HD mice, resulting in elevated cortisol levels,367 that may contribute to impaired glucose metabolism,368 skeletal muscle atrophy, and weight loss.369”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [367]
Citations
Cites
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationDavies, S. W., Turmaine, M., Cozens, B. A., DiFiglia, M., Sharp, A. H., Ross, C. A., Scherzinger, E., Wanker, E. E., Mangiarini, L., & Bates, G. P. (1997) · Cell · doi:10.1016/s0092-8674(00)80513-9 · Cited by 2,181
Self-citationGlucocorticoids and Hippocampal Atrophy in Neuropsychiatric Disorders
Sapolsky, R. M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.10.925 · Cited by 2,016
Physiology and pharmacology of corticotropin-releasing factor.
Owens, M. J., & Nemeroff, C. B. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06673-6 · Cited by 1,142
Adult neurogenesis is regulated by adrenal steroids in the dentate gyrus
Cameron, H. A., & Gould, E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90224-0 · Cited by 998
Carter, R. J., Lione, L. A., Humby, T., Mangiarini, L., Mahal, A., Bates, G. P., Dunnett, S. B., & Morton, A. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-08-03248.1999 · Cited by 947
Self-citationHockly, E., Richon, V. M., Woodman, B., Smith, D. L., Zhou, X., Rosa, E., Sathasivam, K., Ghazi-Noori, S., Mahal, A., Lowden, P. A. S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0437870100 · Cited by 845
Self-citationHuntington disease: Clinical care and evaluation
Shoulson, I., & Fahn, S. (1979) · Neurology · doi:10.1212/wnl.29.1.1 · Cited by 746
Sp1 and TAFII130 Transcriptional Activity Disrupted in Early Huntington's Disease
Dunah, A. W., Jeong, H., Griffin, A., Kim, Y.-M., Standaert, D. G., Hersch, S. M., Mouradian, M. M., Young, A. B., Tanese, N., & Krainc, D. (2002) · Science · doi:10.1126/science.1072613 · Cited by 708
Cha, J.-H. J., Kosinski, C. M., Kerner, J. A., Alsdorf, S. A., Mangiarini, L., Davies, S. W., Penney, J. B., Bates, G. P., & Young, A. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6480 · Cited by 504
Self-citation
Cited by
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease
Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848
Björkqvist, M., Wild, E. J., Thiele, J., Silvestroni, A., Andre, R., Lahiri, N., Raibon, E., Lee, R. V., Benn, C. L., Soulet, D., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080178 · Cited by 650
Self-citationMechanisms of neurodegeneration in Huntington’s disease
Gil, J. M., & Rego, A. C. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06310.x · Cited by 471
Gubert, C., Kong, G., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104621 · Cited by 363
Beyond the brain: widespread pathology in Huntington's disease
van der Burg, J. M., Björkqvist, M., & Brundin, P. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70178-4 · Cited by 363
Self-citationDepression in neurodegenerative diseases: Common mechanisms and current treatment options
Galts, C. P. C., Bettio, L. E. B., Jewett, D. C., Yang, C. C., Brocardo, P. S., Rodrigues, A. L. S., Thacker, J. S., & Gil-Mohapel, J. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.04.002 · Cited by 269
Dalrymple, A., Wild, E. J., Joubert, R., Sathasivam, K., Björkqvist, M., Petersén, Å., Jackson, G. S., Isaacs, J. D., Kristiansen, M., Bates, G. P., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr0700753 · Cited by 228
Self-citationDu, X., & Pang, T. Y. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00032 · Cited by 205
Pang, T. Y. C., Du, X., Zajac, M. S., Howard, M. L., & Hannan, A. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddn385 · Cited by 188
Pathak, N., Vimal, S. K., Tandon, I., Agrawal, L., Cao, H., & Bhattacharyya, S. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00800-w · Cited by 184
Hypothalamic–endocrine aspects in Huntington's disease
Petersén, Å., & Björkqvist, M. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04985.x · Cited by 177
Self-citationHuntington's disease: The current state of research with peripheral tissues
Sassone, J., Colciago, C., Cislaghi, G., Silani, V., & Ciammola, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.05.012 · Cited by 175
Hypothalamic involvement in Huntington's disease: an in vivo PET study
Politis, M., Pavese, N., Tai, Y. F., Tabrizi, S. J., Barker, R. A., & Piccini, P. (2008) · Brain · doi:10.1093/brain/awn244 · Cited by 174
Self-citationMoffitt, H., McPhail, G. D., Woodman, B., Hobbs, C., & Bates, G. P. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008025 · Cited by 156
Self-citationPouladi, M. A., Graham, R. K., Karasinska, J. M., Xie, Y., Santos, R. D., Petersen, A., & Hayden, M. R. (2008) · Brain · doi:10.1093/brain/awp006 · Cited by 145
Self-citationAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
Development of biomarkers for Huntington's disease
Weir, D. W., Sturrock, A., & Leavitt, B. R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70070-9 · Cited by 161
Increased Hypothalamic-Pituitary-Adrenal Axis Activity in Huntington’s Disease
Aziz, N. A., Pijl, H., Frölich, M., van der Graaf, A. W. M., Roelfsema, F., & Roos, R. A. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2543 · Cited by 130
Cholinergic neuronal defect without cell loss in Huntington's disease
Smith, R., Chung, H., Rundquist, S., Maat-Schieman, M. L. C., Colgan, L., Englund, E., Liu, Y.-J., Roos, R. A. C., Faull, R. L. M., Brundin, P., et al. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl252 · Cited by 138
Self-citationIncreased metabolism in the R6/2 mouse model of Huntington’s disease
van der Burg, J. M. M., Bacos, K., Wood, N. I., Lindqvist, A., Wierup, N., Woodman, B., Wamsteeker, J. I., Smith, R., Deierborg, T., Kuhar, M. J., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.029 · Cited by 130
Self-citationBode, F. J., Stephan, M., Suhling, H., Pabst, R., Straub, R. H., Raber, K. A., von Bonin, M., Nguyen, H. P., Rieß, O., Bauer, A., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn159 · Cited by 136
Self-citationThe metabolic profile of early Huntington's disease- a combined human and transgenic mouse study
Goodman, A. O. G., Murgatroyd, P. R., Medina‐Gómez, G., Wood, N. I., Finer, N., Vidal‐Puig, A., Morton, A. J., & Barker, R. A. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.026 · Cited by 133
Gabery, S., Murphy, K., Schultz, K., Loy, C. T., McCusker, E. A., Kirik, D., Halliday, G. M., & Petersén, Å. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0742-6 · Cited by 124
Self-citationMutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits
Hult, S., Soylu-Kucharz, R., Björklund, T., Belgardt, B., Mauer, J., Brüning, J. C., Kirik, D., & Petersén, Å. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.013 · Cited by 122
Self-citationGastrointestinal dysfunction contributes to weight loss in Huntington's disease mice
van der Burg, J. M. M., Winqvist, A., Aziz, N. A., Maat-Schieman, M. L. C., Roos, R. A. C., Bates, G. P., Brundin, P., Björkqvist, M., & Wierup, N. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.006 · Cited by 110
Self-citationMo, C., Hannan, A. J., & Renoir, T. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.03.003 · Cited by 117
Testicular degeneration in Huntington disease
Van Raamsdonk, J. M., Murphy, Z., Selva, D. M., Hamidizadeh, R., Pearson, J., Petersén, Ǻ., Björkqvist, M., Muir, C., Mackenzie, I. R., Hammond, G. L., et al. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.01.006 · Cited by 99
Self-citationMunoz-Sanjuan, I., & Bates, G. P. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45364 · Cited by 109
Self-citationAziz, N. A. (2007) · Reviews in the Neurosciences · doi:10.1515/revneuro.2007.18.3-4.223 · Cited by 94
Genetic Mouse Models of Huntington’s Disease: Focus on Electrophysiological Mechanisms
Cepeda, C., Cummings, D. M., André, V. M., Holley, S. M., & Levine, M. S. (2010) · ASN Neuro · doi:10.1042/an20090058 · Cited by 93
Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
Pla, P., Orvoen, S., Saudou, F., David, D. J., & Humbert, S. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00135 · Cited by 91
Kohl, Z., Kandasamy, M., Winner, B., Aigner, R., Groß, C., Couillard‐Després, S., Bogdahn, U., Aigner, L., & Winkler, J. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.039 · Cited by 100
Sexually Dimorphic Serotonergic Dysfunction in a Mouse Model of Huntington's Disease and Depression
Renoir, T., Zajac, M. S., Du, X., Pang, T. Y., Leang, L., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022133 · Cited by 90
Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis
Soneson, C., Fontes, M., Zhou, Y., Denisov, V., Paulsen, J. S., Kirik, D., & Petersén, Å. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.013 · Cited by 81
Self-citationLundh, S. H., Nilsson, N., Soylu-Kucharz, R., Kirik, D., & Petersén, Å. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt203 · Cited by 83
Self-citationRenoir, T., Pang, T. Y., Zajac, M. S., Chan, G., Du, X., Leang, L., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01567.x · Cited by 70
Du, X., Leang, L., Mustafa, T., Renoir, T., Pang, T. Y., & Hannan, A. J. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.58 · Cited by 75
Lazic, S. E., Goodman, A. O. G., Grote, H., Blakemore, C., Morton, A. J., Hannan, A. J., van Dellen, A., & Barker, R. A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.03.018 · Cited by 73
Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis
Chuang, C.-L., & Demontis, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101358 · Cited by 64
The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease
Gil‐Mohapel, J., & Rego, A. C. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.001 · Cited by 69
Gil‐Mohapel, J., Simpson, J. M., Ghilan, M., & Christie, B. R. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.040 · Cited by 68
Rattray, I., Smith, E. J., Crum, W. R., Walker, T. A., Gale, R., Bates, G. P., & Modo, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084726 · Cited by 68
Self-citationShe, P., Zhang, Z., Marchionini, D. M., Diaz, W. C., Jetton, T. J., Kimball, S. R., Vary, T. C., Lang, C. H., & Lynch, C. J. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00630.2010 · Cited by 69
Träger, U., Andre, R., Magnusson-Lind, A., Miller, J. R. C., Connolly, C., Weiss, A., Grueninger, S., Silajdžić, E., Smith, D. L., Leavitt, B. R., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.012 · Cited by 63
Self-citationA Metabolic Study of Huntington’s Disease
Nambron, R., Silajdžić, E., Kalliolia, E., Ottolenghi, C., Hindmarsh, P. C., Hill, N. R., Costelloe, S. J., Martin, N. G., Positano, V., Watt, H., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146480 · Cited by 64
Self-citationMouse Models of Polyglutamine Diseases: Review and Data Table. Part I
Figiel, M., Szlachcic, W. J., Switonski, P. M., Gabka, A., & Krzyżosiak, W. J. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8315-4 · Cited by 63
Hypothalamic and Limbic System Changes in Huntington's Disease
Petersén, Å., & Gabery, S. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-2012-120006 · Cited by 59
Self-citationA Critical Evaluation of Wet Biomarkers for Huntington’s Disease: Current Status and Ways Forward
Silajdžić, E., & Björkqvist, M. (2018) · Journal of Huntington s Disease · doi:10.3233/jhd-170273 · Cited by 58
Self-citationGlucocorticoid receptor signaling in the brain and its involvement in cognitive function
Su, C., Huang, T., Zhang, M., Zhang, Y., Zeng, Y., & Chen, X. Y. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00355 · Cited by 57
Altered lipid metabolism in Drosophila model of Huntington’s disease
Aditi, K., Shakarad, M. N., & Agrawal, N. (2016) · Scientific Reports · doi:10.1038/srep31411 · Cited by 49
Renoir, T., Pang, T. Y., Mo, C., Chan, G., Chevarin, C., Lanfumey, L., & Hannan, A. J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.239798 · Cited by 53
Mo, C., Renoir, T., & Hannan, A. J. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.08.008 · Cited by 53
van Duijn, E., Selis, M. A., Giltay, E. J., Zitman, F. G., Roos, R. A. C., van Pelt, H., & van der Mast, R. C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.08.006 · Cited by 53
Cortisol and depression in pre-diagnosed and early stage Huntington's disease
Shirbin, C. A., Chua, P. M.-L., Churchyard, A., Lowndes, G., Hannan, A. J., Pang, T. Y., Chiu, E. Y.-K., & Stout, J. C. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.10.020 · Cited by 53
Hölter, S. M., Stromberg, M., Kovalenko, M. V., Garrett, L., Glasl, L., Lopez, E., Guide, J. R., Götz, A. A., Hans, W., Becker, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080923 · Cited by 49
Yamanaka, T., Tosaki, A., Miyazaki, H., Kurosawa, M., Furukawa, Y., Yamada, M., & Nukina, N. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq087 · Cited by 44
Effects of chronic stress on the onset and progression of Huntington’s disease in transgenic mice
Mo, C., Renoir, T., & Hannan, A. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.008 · Cited by 46
Littin, K. E., Acevedo‐Arozena, A., Browne, W. J., Edgar, J. L., Mendl, M., Owen, D., Sherwin, C. M., Würbel, H., & Nicol, C. J. (2008) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2008.0388 · Cited by 46
A comprehensive perspective of Huntington’s disease and mitochondrial dysfunction
Dai, Y., Wang, H., Lian, A., Li, J., Zhao, G., Hu, S., & Li, B. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.03.001 · Cited by 45
Regulation of intracellular HAP1 trafficking
Rong, J., Li, S., & Li, X. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21326 · Cited by 43
Why Woody got the blues: The neurobiology of depression in Huntington's disease
Gubert, C., Renoir, T., & Hannan, A. J. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104958 · Cited by 42
Nicola, A. F. D., Meyer, M., Guennoun, R., Schumacher, M., Hunt, H., Belanoff, J. K., de Kloet, E. R., & Deniselle, M. C. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062137 · Cited by 41
Hubers, A. A. M., van der Mast, R. C., Pereira, A. M., Roos, R. A. C., Veen, L. J., Cobbaert, C. M., van Duijn, E., & Giltay, E. J. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12255 · Cited by 41
The Role of Hypothalamic Pathology for Non-Motor Features of Huntington’s Disease
Cheong, R. Y., Gabery, S., & Petersén, Å. (2019) · Journal of Huntington s Disease · doi:10.3233/jhd-190372 · Cited by 39
Self-citationHigh stress hormone levels accelerate the onset of memory deficits in male Huntington's disease mice
Mo, C., Pang, T. Y., Ransome, M. I., Hill, R. A., Renoir, T., & Hannan, A. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.004 · Cited by 34
Reduced gluconeogenesis and lactate clearance in Huntington's disease
Josefsen, K. E., Nielsen, S. M. B., Campos, A., Seifert, T., Hasholt, L., Nielsen, J. E., Nørremølle, A., Skotte, N. H., Secher, N. H., & Quistorff, B. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.08.009 · Cited by 39
IGF-1 protects against diabetic features in an in vivo model of Huntington's disease
Duarte, A. I., Petit, G. H., Ranganathan, S., Li, J.-Y., Oliveira, C. R., Brundin, P., Björkqvist, M., & Rego, A. C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.016 · Cited by 38
Self-citationDu, X., Pang, T. Y., & Hannan, A. J. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00081 · Cited by 38
Du, X., Pang, T. Y., Mo, C., Renoir, T., Wright, D. J., & Hannan, A. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.09.009 · Cited by 37
AAV5-miHTT-mediated huntingtin lowering improves brain health in a Huntington’s disease mouse model
Thomson, S. B., Stam, A., Brouwers, C. C., Fodale, V., Bresciani, A., Vermeulen, M., Mostafavi, S., Petkau, T. L., Hill, A., Yung, A. C., et al. (2022) · Brain · doi:10.1093/brain/awac458 · Cited by 36
van der Borght, K., & Brundin, P. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.10.014 · Cited by 36
Self-citationShort-term memory acquisition in female Huntington's disease mice is vulnerable to acute stress
Mo, C., Renoir, T., Pang, T. Y., & Hannan, A. J. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.07.041 · Cited by 34
Islet β-cell area and hormone expression are unaltered in Huntington’s disease
Bacos, K., Björkqvist, M., Petersén, Å., Luts, L., Maat–Schieman, M. L. C., Roos, R. A. C., Sundler, F., Brundin, P., Mulder, H., & Wierup, N. (2008) · Histochemistry and Cell Biology · doi:10.1007/s00418-008-0393-z · Cited by 34
Self-citationEnvironmental stimulation in Huntington disease patients and animal models
Novati, A., Nguyen, H. P., & Schulze-Hentrich, J. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105725 · Cited by 32
Altered thyrotropic and lactotropic axes regulation in Huntington’s disease
Aziz, N. A., Pijl, H., Frölich, M., Roelfsema, F., & Roos, R. A. C. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03836.x · Cited by 32
Shen, J., Wang, X., Wang, M., & Zhang, H. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1337442 · Cited by 31
A 24-Hour Study of the Hypothalamo-Pituitary Axes in Huntington’s Disease
Kalliolia, E., Silajdžić, E., Nambron, R., Costelloe, S. J., Martin, N. G., Hill, N. R., Frost, C. D., Watt, H., Hindmarsh, P. C., Björkqvist, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138848 · Cited by 30
Self-citationHuntington’s Disease – New Perspectives Based on Neuroendocrine Changes in Rodent Models
Petersén, Å., Hult, S., & Kirik, D. (2009) · Neurodegenerative Diseases · doi:10.1159/000225377 · Cited by 29
Self-citationManagement of altered metabolic activity in Drosophila model of Huntington’s disease by curcumin
Aditi, K., Singh, A., Shakarad, M., & Agrawal, N. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211046927 · Cited by 29
Bartlett, D. M., Cruickshank, T. M., Hannan, A. J., Eastwood, P. R., Lázár, A. S., & Ziman, M. R. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.09.006 · Cited by 29
Goodman, A. O. G., & Barker, R. A. (2011) · PLoS Currents · doi:10.1371/currents.rrn1214 · Cited by 28
The relationship between cortisol and verbal memory in the early stages of Huntington’s disease
Shirbin, C. A., Chua, P. M.-L., Churchyard, A., Hannan, A. J., Lowndes, G., & Stout, J. C. (2012) · Journal of Neurology · doi:10.1007/s00415-012-6732-y · Cited by 28
Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
Lee, D.-H., Heidecke, H., Schröder, A., Paul, F., Wachter, R., Hoffmann, R., Ellrichmann, G., Dragun, D., Waschbisch, A., Stegbauer, J., et al. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-49 · Cited by 26
Ghrelin rescues skeletal muscle catabolic profile in the R6/2 mouse model of Huntington’s disease
Sjögren, M., Duarte, A. I., McCourt, A. C., Shcherbina, L., Wierup, N., & Björkqvist, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-13713-5 · Cited by 26
Self-citationWilliams, S., & Ghosh, C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.009 · Cited by 26
High Prevalence of Diabetes Mellitus in a Five-Generation Chinese Family with Huntington's Disease
Hu, Y., Liang, J., & Yu, S. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131847 · Cited by 25
Zucker, B., Kama, J. A., Kuhn, A., Thu, D. C. V., Orlando, L. R., Dunah, A. W., Gökçe, Ö., Taylor, D. M., Lambeck, J., Friedrich, B., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ed7a41 · Cited by 24
Naia, L., Ribeiro, M. J., & Rego, A. C. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.060 · Cited by 24
Dufour, B. D., & McBride, J. L. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.028 · Cited by 24
Neuroendocrine Disturbances in Neurodegenerative Disorders: A Scoping Review
Newhouse, A. L., & Chemali, Z. N. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.11.002 · Cited by 24
Hypothalamic expression of huntingtin causes distinct metabolic changes in Huntington's disease mice
Dickson, E., Soylu-Kucharz, R., Petersén, Å., & Björkqvist, M. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101439 · Cited by 22
Self-citationParaventricular Nucleus Neuropeptide Expression in Huntington's Disease Patients
van Wamelen, D. J., Aziz, N. A., Anink, J. J., Roos, R. A. C., & Swaab, D. F. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00565.x · Cited by 21
Hypothalamic overexpression of mutant huntingtin causes dysregulation of brown adipose tissue
Soylu-Kucharz, R., Adlesic, N., Baldo, B., Kirik, D., & Petersén, Å. (2015) · Scientific Reports · doi:10.1038/srep14598 · Cited by 21
Self-citationOuk, K., Aungier, J., & Morton, A. J. (2016) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.004 · Cited by 19
Oral and dental health in Huntington‘s disease - an observational study
Carsten Saft, C., Andrich, J., Müller, T. H., Becker, J., & Jackowski, J. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-114 · Cited by 19
Dufour, B. D., & McBride, J. L. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.09.025 · Cited by 19
Sjögren, M., Soylu-Kucharz, R., Dandunna, U., Stan, T., Cavalera, M., Sandelius, Å., Zetterberg, H., & Björkqvist, M. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104560 · Cited by 15
Self-citationSelvaraj, K., Manickam, N., Kumaran, E., Thangadurai, K., Elumalai, G., Sekar, A., Radhakrishnan, R. K., & Kandasamy, M. (2019) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105526 · Cited by 16
Advances in Huntington Disease Drug Discovery: Novel Approaches to Model Disease Phenotypes
Bard, J., Wall, M. D., Lazari, O., Arjomand, J., & Muñoz-Sanjuán, I. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113510320 · Cited by 18
Characteristics, Pathophysiology and Clinical Management of Weight Loss in Huntington’s Disease
Aziz, N. A., & Roos, R. A. C. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.22 · Cited by 17
Metadata
- Authors
- Björkqvist, M., Petersén, Å., Bacos, K., Isaacs, J., Norlén, P., Gil, J., Popovic, N., Sundler, F., Bates, G. P., Tabrizi, S. J., Brundin, P., & Mulder, H.
- Affiliations
- Lund University (SE)
- Corresponding author
- Björkqvist, Maria
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-04-13
- Volume
- 15
- Issue
- 10
- Pages
- 1713-1721
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2164413723
- Cited by
- 138
- References
- 48
- Citations by year
- 2025: 3 · 2024: 7 · 2023: 4 · 2022: 5 · 2021: 6 · 2020: 3 · 2019: 8 · 2018: 2 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 10 · 2012: 8
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- Huntington's disease, R6/2 transgenic mice, hypothalamic-pituitary-adrenal axis, corticosterone, ACTH, dopamine D2 receptor, adrenal cortex hypertrophy, insulin resistance, bone mineral density, muscle atrophy, urinary cortisol, disease progression
- MeSH terms
- Huntingtin Protein, Adrenocorticotropic Hormone, Adult, Animals, Corticosterone, Disease Models, Animal, Dopamine, Female, Humans, Huntington Disease, Hydrocortisone, Hypothalamo-Hypophyseal System, Insulin Resistance, Male, Mice, Transgenic, Middle Aged, Muscular Atrophy, Nerve Tissue Proteins, Nuclear Proteins, Pituitary-Adrenal System, Bone Density, Receptors, Dopamine D2, Body Fat Distribution, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.